Henan Lingrui Pharmaceutical Co., Ltd. provided earnings guidance for the full year 2015. For the period, the company expects year-on-year increase of between 65% and 85% in its net profit owned by shareholders.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.21 CNY | -0.66% | -2.34% | +41.50% |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
04-25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.50% | 1.9B | |
+37.29% | 6.09B | |
-21.28% | 4.14B | |
+4.52% | 3.23B | |
-18.16% | 2.83B | |
-7.70% | 2.39B | |
-4.05% | 1.57B | |
-15.56% | 1.55B | |
-14.62% | 1.5B | |
+40.06% | 1.43B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Henan Lingrui Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2015